190 related articles for article (PubMed ID: 20334627)
21. Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).
von Hunolstein C; D'Ascenzi S; Wagner B; Jelínková J; Alfarone G; Recchia S; Wagner M; Orefici G
Infect Immun; 1993 Apr; 61(4):1272-80. PubMed ID: 8454331
[TBL] [Abstract][Full Text] [Related]
22. Sialic acid utilization by bacterial pathogens.
Severi E; Hood DW; Thomas GH
Microbiology (Reading); 2007 Sep; 153(Pt 9):2817-2822. PubMed ID: 17768226
[TBL] [Abstract][Full Text] [Related]
23. Virulence properties of type VII Streptococcus agalactiae (group B streptococci) and immunochemical analysis of capsular type polysaccharide.
VON Hunolstein C; Parisi L; Tissi L; Recchia S; Alfarone G; Nicolini L; Volpe C; Wagner B; Motlova J; Orefici G
J Med Microbiol; 1999 Nov; 48(11):983-990. PubMed ID: 10535641
[TBL] [Abstract][Full Text] [Related]
24. Growth of group B streptococci in human serum leads to increased cell surface sialic acid and decreased activation of the alternative complement pathway.
Platt MW; Correa N; Mold C
Can J Microbiol; 1994 Feb; 40(2):99-105. PubMed ID: 8019940
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the capsule synthesis locus, a virulence factor in group B streptococci.
Yim HH; Nittayarin A; Rubens CE
Adv Exp Med Biol; 1997; 418():995-7. PubMed ID: 9331818
[No Abstract] [Full Text] [Related]
26. Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule.
Wessels MR; Rubens CE; Benedí VJ; Kasper DL
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8983-7. PubMed ID: 2554337
[TBL] [Abstract][Full Text] [Related]
27.
Joyce LR; Kim S; Spencer BL; Christensen PM; Palmer KL; Guan Z; Siegenthaler JA; Doran KS
Sci Adv; 2024 May; 10(22):eadn7848. PubMed ID: 38809989
[No Abstract] [Full Text] [Related]
28. Group B Streptococcus engages an inhibitory Siglec through sialic acid mimicry to blunt innate immune and inflammatory responses in vivo.
Chang YC; Olson J; Beasley FC; Tung C; Zhang J; Crocker PR; Varki A; Nizet V
PLoS Pathog; 2014 Jan; 10(1):e1003846. PubMed ID: 24391502
[TBL] [Abstract][Full Text] [Related]
29. Role of group B streptococcal capsular polysaccharides in the induction of septic arthritis.
Tissi L; von Hunolstein C; Bistoni F; Marangi M; Parisi L; Orefici G
J Med Microbiol; 1998 Aug; 47(8):717-23. PubMed ID: 9877193
[TBL] [Abstract][Full Text] [Related]
30. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence.
Rubens CE; Wessels MR; Heggen LM; Kasper DL
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7208-12. PubMed ID: 2823254
[TBL] [Abstract][Full Text] [Related]
31. Surface Structures of Group B
Paoletti LC; Kasper DL
Microbiol Spectr; 2019 Mar; 7(2):. PubMed ID: 30873933
[TBL] [Abstract][Full Text] [Related]
32. Genetic bases and medical relevance of capsular polysaccharide biosynthesis in pathogenic streptococci.
Llull D; López R; García E
Curr Mol Med; 2001 Sep; 1(4):475-91. PubMed ID: 11899092
[TBL] [Abstract][Full Text] [Related]
33. Group B Streptococcus and Streptococcus suis capsular polysaccharides induce chemokine production by dendritic cells via Toll-like receptor 2- and MyD88-dependent and -independent pathways.
Calzas C; Goyette-Desjardins G; Lemire P; Gagnon F; Lachance C; Van Calsteren MR; Segura M
Infect Immun; 2013 Sep; 81(9):3106-18. PubMed ID: 23774593
[TBL] [Abstract][Full Text] [Related]
34. Identification of Zinc-Dependent Mechanisms Used by Group B
Burcham LR; Le Breton Y; Radin JN; Spencer BL; Deng L; Hiron A; Ransom MR; Mendonça JDC; Belew AT; El-Sayed NM; McIver KS; Kehl-Fie TE; Doran KS
mBio; 2020 Nov; 11(6):. PubMed ID: 33173000
[TBL] [Abstract][Full Text] [Related]
35. Group B Streptococcus Biofilm Regulatory Protein A Contributes to Bacterial Physiology and Innate Immune Resistance.
Patras KA; Derieux J; Al-Bassam MM; Adiletta N; Vrbanac A; Lapek JD; Zengler K; Gonzalez DJ; Nizet V
J Infect Dis; 2018 Oct; 218(10):1641-1652. PubMed ID: 29868829
[TBL] [Abstract][Full Text] [Related]
36. Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.
Paoletti LC; Wessels MR; Michon F; DiFabio J; Jennings HJ; Kasper DL
Infect Immun; 1992 Oct; 60(10):4009-14. PubMed ID: 1398913
[TBL] [Abstract][Full Text] [Related]
37. Hyaluronidase Impairs Neutrophil Function and Promotes Group B
Coleman M; Armistead B; Orvis A; Quach P; Brokaw A; Gendrin C; Sharma K; Ogle J; Merillat S; Dacanay M; Wu TY; Munson J; Baldessari A; Vornhagen J; Furuta A; Nguyen S; Adams Waldorf KM; Rajagopal L
mBio; 2021 Jan; 12(1):. PubMed ID: 33402537
[TBL] [Abstract][Full Text] [Related]
38. Sialic acid involved in hypermucoviscosity phenotype of Klebsiella pneumoniae and associated with resistance to neutrophil phagocytosis.
Lee CH; Chang CC; Liu JW; Chen RF; Yang KD
Virulence; 2014 Aug; 5(6):673-9. PubMed ID: 25098744
[TBL] [Abstract][Full Text] [Related]
39. Sialylation of Streptococcus suis serotype 2 is essential for capsule expression but is not responsible for the main capsular epitope.
Lecours MP; Fittipaldi N; Takamatsu D; Okura M; Segura M; Goyette-Desjardins G; Van Calsteren MR; Gottschalk M
Microbes Infect; 2012 Sep; 14(11):941-50. PubMed ID: 22521569
[TBL] [Abstract][Full Text] [Related]
40. Construction of Streptococcus agalactiae sialic acid mutant and evaluation of its potential as a live attenuated vaccine in Nile tilapia (Oreochromis niloticus).
Hao J; Wang S; Wei Z; Zhang Q; Wu Z; Lin Y; Yang J; Zhang J; Zhang D; Li A
J Appl Microbiol; 2022 Oct; 133(4):2403-2416. PubMed ID: 35801502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
